# Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients

> **NCT06556134** · PHASE4 · COMPLETED · sponsor: **Centre Hospitalier Hassan II - Fès** · enrollment: 27 (actual)

## Conditions studied

- Anemia of Chronic Kidney Disease

## Interventions

- **DRUG:** Intravenous Iron Sucrose
- **DRUG:** Oral Iron

## Key facts

- **NCT ID:** NCT06556134
- **Lead sponsor:** Centre Hospitalier Hassan II - Fès
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2024-01-10
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06556134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06556134, "Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06556134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*